PROCEPT BioRobotics Corp Files Q2 2024 10-Q
Ticker: PRCT · Form: 10-Q · Filed: Aug 2, 2024 · CIK: 1588978
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
PROCEPT BioRobotics Corp's Q2 2024 10-Q is in. Check financials.
AI Summary
PROCEPT BioRobotics Corp filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key financial figures and balance sheet information are presented, reflecting the company's status in the surgical and medical instruments sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational performance of PROCEPT BioRobotics Corp, crucial for understanding its market position and future prospects.
Risk Assessment
Risk Level: medium — As a publicly traded company in the medical device sector, PROCEPT BioRobotics Corp faces inherent risks related to regulatory approvals, market competition, and financial performance.
Key Numbers
- Q2 2024 — Reporting Period (The second quarter of 2024, for which financial results are reported.)
- 12/31 — Fiscal Year End (Indicates the company's fiscal year concludes on December 31st.)
Key Players & Entities
- PROCEPT BioRobotics Corp (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 20240802 (date) — Filing date
- 150 BAYTECH DRIVE, SAN JOSE, CA 95134 (address) — Company's business and mailing address
- 6502329832 (phone_number) — Company's business phone number
FAQ
What is the primary business of PROCEPT BioRobotics Corp?
PROCEPT BioRobotics Corp operates in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending June 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on August 2, 2024.
What is the company's state of incorporation?
PROCEPT BioRobotics Corp is incorporated in Delaware (DE).
What are the company's main addresses?
The company's business and mailing address is 150 BAYTECH DRIVE, SAN JOSE, CA 95134.
Filing Stats: 4,695 words · 19 min read · ~16 pages · Grade level 14.2 · Accepted 2024-08-02 16:29:58
Key Financial Figures
- $0.00001 — ange on which registered Common stock, $0.00001 par value per share PRCT Nasdaq Global
Filing Documents
- prct-20240630.htm (10-Q) — 862KB
- prct-ex311soxcertification.htm (EX-31.1) — 10KB
- prct-ex312soxcertification.htm (EX-31.2) — 10KB
- prct-ex321soxcertification.htm (EX-32.1) — 6KB
- prct-ex322soxcertification.htm (EX-32.2) — 6KB
- 0001588978-24-000020.txt ( ) — 5442KB
- prct-20240630.xsd (EX-101.SCH) — 34KB
- prct-20240630_cal.xml (EX-101.CAL) — 59KB
- prct-20240630_def.xml (EX-101.DEF) — 151KB
- prct-20240630_lab.xml (EX-101.LAB) — 523KB
- prct-20240630_pre.xml (EX-101.PRE) — 353KB
- prct-20240630_htm.xml (XML) — 789KB
Financial Information
Part I. Financial Information Item 1. Condensed Consolidated Financial Statements (unaudited) 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Operations and Comprehensive Loss 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3. Quantitative and Qualitative Disclosure About Market Risk 24 Item 4.
Controls and Procedures
Controls and Procedures 25
Other Information
Part II. Other Information Item 1.
Legal Proceedings
Legal Proceedings 26 Item 1A.
Risk Factors
Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26 Item 3. Defaults Upon Senior Securities 26 Item 4. Mine Safety Disclosures 26 Item 5. Other Information 26 Item 6. Exhibits 28
Signatures
Signatures __________________ 2 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "can", "will," "would," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential," or "continue" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. All statements other than statements of historical facts contained in this Quarterly Report, including without limitation statements regarding our business model and strategic plans for our products, technologies and business, including our implementation thereof, the timing of and our ability to obtain and maintain regulatory approvals, our commercialization, marketing and manufacturing capabilities and strategy, our expectations about the commercial success and market acceptance of our products, the sufficiency of our cash, cash equivalents and short-term investments, and the plans and objectives of management for future operations and capital expenditures are forward-looking statements. The forward-looking statements in this Quarterly Report are only predictions and are based largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of known and unknown risks, uncertainties, and assumptions, including those described under the sections in this Quarterly Report entitled "Risk Factors" and "